Tag
PharmAla Biotech
- CNS drug specialist Jupiter Neuro signs MDMA deal with PharmAla Biotech
- Filament Health ships psilocybin drug to Australia, first country legally prescribing psychedelics
- PharmAla Biotech ships first batch of MDMA and psilocybin to be used as medicines in Australia
- PharmAla Biotech lists on the OTCQB middle-tier venture market
- PharmAla Biotech secures first purchase order for GMP LaNeo MDMA in Australia
- PharmAla Biotech first to get Special Access Program authorization for its MDMA
- Incannex orders psilocybin and MDMA from PharmAla Biotech
- PharmAla Biotech signs agreement to sell clinical-grade MDMA in Australia
- Psyched Wellness formulates first commercial Amanita muscaria extract
- PharmAla Biotech gets Health Canada approval to export large MDMA shipment to the U.K.
- PharmAla and Mindset enter psilocybin distribution agreement
- PsyCan aims to be ‘go‑to’ psychedelics industry organization, receives support from lawmakers
- PsyCan pushes federal policy-makers to lift restrictions on psychedelics
- PharmAla Biotech to provide University of Sydney with LaNeo MDMA for clinical studies
- PharmAla Biotech applies for patent on 6 novel MDMA-like molecules
- PharmAla Biotech becomes first public company producing GMP MDMA
- PharmAla Biotech initiates MDMA supplier agreement with InterVivo